BioMarin Pharmaceutical Inc. (BMRN) plummeted -2.11 percent and ended the day at $87.32. The Average Volume of the company is 1.27 Million and P/E (price to earnings) ratio is 0, while Forward P/E ratio is 0.
The stock has a Return on Assets of -15.1 percent, Return on Investment of -17.5 percent and a Return on Equity of -22.2 percent. The company’s market cap is $14.97 Billion.
A price target is the projected price level of a financial security stated by an investment analyst. It represents a security’s price that, if achieved, results in a trader recognizing the best possible outcome for his investment. This is the price at which the trader or investor wants to exit his existing position so he can realize the most reward.
BioMarin Pharmaceutical Inc. (BMRN) has been given an average price target of $113.83 from analysts, according to data collected by Finviz.
Now we look at the Moving Averages, the 200-day is -1.42, the 50-day is -3.27 and the 20-day is -2.69. Moving averages are used as a strong indicator for technical stock analysis and it helps investors in figuring out where the stock has been and also help in determining where it may be possibly heading.
Looking forward, the company is expected to report earnings of $-0.24 per share for the current quarter. Revenue is expected in between 333.11 Million and 305.12 Million with an average of 318.31 Million.
BioMarin Pharmaceutical Inc. (BMRN) has an Analysts’ Mean Recommendation of 1.9, according to data compiled by Finviz. The recommendation scale measures the value from 1 to 5, where 1 means ‘’Buy’’ and 5 stands for ’’Sell’’.
BioMarin Pharmaceutical Inc. was covered by a number of analysts recently, 7 rated the stock as Buy, 8 rated Outperform, 4 rated Hold, 0 gave an Underperform and 0 rated sell.
BioMarin Pharmaceutical Inc. (BMRN) performance during the last one year Degraded -10.98 percent, while its year to date (YTD) performance showed a Positive trend of 5.41 percent. The stock Jumped 2.39 percent over the past six months. The stock’s quarterly performance indicates a Negative momentum of -9.29 percent, whereas its last one month trend is Pessimistic with -2.58 percent. Its weekly performance showed downward trend of -0.48 percent.
Profitability analysis helps a great deal in making investment decision. Net profit margin of the company was recorded at -47.4 percent, operating profit margin was -62.7 percent, whereas gross profit margin stands at 81.7 percent. Beta factor was calculated at 1.83.
BioMarin Pharmaceutical Inc. (BMRN) has 171.48 Million shares outstanding and 171.48 Million shares were floated in market. The short ratio in the company’s stock is documented at 6.09 and the short float is around of 4.5%. The stock’s average true range of stands at 2.52, while the relative strength index is 43.94.
Liquidity ratios helps investors to determine a company’s ability to pay off its debts. For the most recent quarter, quick ratio was 2.8, current ratio was 4, LT Debt/Equity ratio was 0.24 and Total Debt/Equity ratio was 0.25.